Shigeki Bamba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Shigeki Bamba has a total of 377 co-authors. Here are the top co-authors by number of shared publications:
- Osamu Inatomi
Department of Gastroenterology, Shiga University of Medical Science, Otsu, Japan
26 shared publications Masaya Sasaki
Division of Clinical Nutrition Shiga University of Medical Science Otsu Japan
21 shared publicationsAkira Andoh
Department of Gastroenterology Shiga University Medical Science Shiga Japan
19 shared publications- Akira Andoh
Department of Medicine Shiga University of Medical Science
19 shared publications Tomoyuki Tsujikawa
Department of Gastroenterology, National Hospital Organization Higashi-Ohmi General Medical Center, Higashi-Ohmi, Japan
19 shared publicationsYoshihide Fujiyama
19 shared publications
Latest Publications
- Open Access
- 7 November 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (11)
Treatment patterns and determinants of persistence with advanced therapies in adults with newly diagnosed Crohn’s disease: an interim analysis of an inception cohort registry study (iCREST-CD)
Background and Aims: Multiple advanced therapies are available for the treatment of Crohn’s disease (CD). Treatment patterns in newly diagnosed patients and the factors associated with persistence remain unclear. We present interim results of the iCREST-CD registry describing treatment patterns and persistence with advanced therapies. Methods: Patients aged ≥16 years with newly diagnosed CD and who had no prior exposure to advanced therapies were enrolled. Persistence of advanced therapies was estimated using Kaplan–Meier analyses, and associated factors were identified using multivariable Cox proportional hazards models. Persistence was also compared between patients who initiated therapy early or later after diagnosis. Results: Of 672 patients (68.2% male; mean age 29.4 ± 13.1 years), 498 (74.1%) initiated advanced therapy: infliximab (IFX; 121), adalimumab (ADA; 244), ustekinumab (UST; 107), or vedolizumab (VDZ; 26). Advanced therapy was initiated within 1 year of diagnosis in 404 (60.1%). The 36-month treatment persistence rates for IFX, ADA, UST, and VDZ were 77.5%, 75.7%, 79.8%, and 49.0%, respectively. After propensity score adjustment using inverse probability of treatment weighting, the early initiation was associated with greater persistence than delayed initiation, although the difference did not reach statistical significance (hazard ratio, 0.61; 95% confidence interval, 0.35-1.09; P = .067). Conclusions: A high prevalence of early advanced therapy use and a high level of persistence with first-line advanced therapy were identified in this national cohort. Early initiation was associated with greater treatment persistence than delayed initiation, suggesting the potential clinical relevance of earlier advanced therapy use in routine practice. These findings require confirmation in other prospective studies aiming to evaluate early intervention strategies. Registration: The study was registered with the University Hospital Medical Information Network Clinical Trials Registry (umin.ac.jp/ctr Identifier: UMIN000032237) prior to initiation.
- 7 November 2026
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 20 (11)
Open AccessTreatment patterns and determinants of persistence with advanced therapies in adults with newly diagnosed Crohn’s disease: an interim analysis of an inception cohort registry study (iCREST-CD)
Background and Aims: Multiple advanced therapies are available for the treatment of Crohn’s disease (CD). Treatment patterns in newly diagnosed patients and the factors associated with persistence remain unclear. We present interim results of the iCREST-CD registry describing treatment patterns and persistence with advanced therapies. Methods: Patients aged ≥16 years with newly diagnosed CD and who had no prior exposure to advanced therapies were enrolled. Persistence of advanced therapies was estimated using Kaplan–Meier analyses, and associated factors were identified using multivariable Cox proportional hazards models. Persistence was also compared between patients who initiated therapy early or later after diagnosis. Results: Of 672 patients (68.2% male; mean age 29.4 ± 13.1 years), 498 (74.1%) initiated advanced therapy: infliximab (IFX; 121), adalimumab (ADA; 244), ustekinumab (UST; 107), or vedolizumab (VDZ; 26). Advanced therapy was initiated within 1 year of diagnosis in 404 (60.1%). The 36-month treatment persistence rates for IFX, ADA, UST, and VDZ were 77.5%, 75.7%, 79.8%, and 49.0%, respectively. After propensity score adjustment using inverse probability of treatment weighting, the early initiation was associated with greater persistence than delayed initiation, although the difference did not reach statistical significance (hazard ratio, 0.61; 95% confidence interval, 0.35-1.09; P = .067). Conclusions: A high prevalence of early advanced therapy use and a high level of persistence with first-line advanced therapy were identified in this national cohort. Early initiation was associated with greater treatment persistence than delayed initiation, suggesting the potential clinical relevance of earlier advanced therapy use in routine practice. These findings require confirmation in other prospective studies aiming to evaluate early intervention strategies. Registration: The study was registered with the University Hospital Medical Information Network Clinical Trials Registry (umin.ac.jp/ctr Identifier: UMIN000032237) prior to initiation.
- Open Access
- 1 March 2026
- Vol. 31 (2) , e70404
Predictors for Home Discharge and Need for Medical Care at Home in Paediatric ICU Patients: A Single-Centre Retrospective Study.
The number of children with medical complexity at home has been increasing. To facilitate a smooth transition to home care for these children after discharge from the intensive care unit (ICU), early nursing interventions and family training are essential. This study examined factors that predict home discharge and the need for medical care at home using routine clinical information at the time of ICU admission. This study included paediatric patients under the age of 16 who were admitted to the ICU. Clinical data were extracted from medical records. Univariate and multivariate analyses were conducted using logistic regression to identify relevant factors. Receiver operating characteristic (ROC) analysis was performed to determine the cut-off values. One hundred and thirty-one patients were included, of whom 82 patients were discharged home. Multivariate analysis using logistic regression identified the following independent predictors of home discharge: postoperative admission (p = 0.024), lower heart rate at admission (p = 0.016), absence of cardiopulmonary arrest immediately before ICU admission (CPA) (p = 0.012) and no mechanical ventilation within the first hour of ICU admission (p = 0.044). ROC analysis for heart rate at admission yielded a cut-off value of 131 bpm (p = 0.039). A total of 62 patients did not require home medical care. Univariate logistic regression analysis identified length of ICU stay as a significant factor associated with the need for home medical care (p = 0.045). In paediatric ICU patients, postoperative admission, lower heart rate at admission, absence of pre-admission CPA and no mechanical ventilation predicted successful home discharge. The need for home medical care was significantly associated with length of ICU stay. Early and appropriate nursing interventions can be considered for paediatric ICU patients and their families, leading to the provision of high-quality nursing care.
- 1 March 2026
- Vol. 31 (2) , e70404
Open AccessPredictors for Home Discharge and Need for Medical Care at Home in Paediatric ICU Patients: A Single-Centre Retrospective Study.
The number of children with medical complexity at home has been increasing. To facilitate a smooth transition to home care for these children after discharge from the intensive care unit (ICU), early nursing interventions and family training are essential. This study examined factors that predict home discharge and the need for medical care at home using routine clinical information at the time of ICU admission. This study included paediatric patients under the age of 16 who were admitted to the ICU. Clinical data were extracted from medical records. Univariate and multivariate analyses were conducted using logistic regression to identify relevant factors. Receiver operating characteristic (ROC) analysis was performed to determine the cut-off values. One hundred and thirty-one patients were included, of whom 82 patients were discharged home. Multivariate analysis using logistic regression identified the following independent predictors of home discharge: postoperative admission (p = 0.024), lower heart rate at admission (p = 0.016), absence of cardiopulmonary arrest immediately before ICU admission (CPA) (p = 0.012) and no mechanical ventilation within the first hour of ICU admission (p = 0.044). ROC analysis for heart rate at admission yielded a cut-off value of 131 bpm (p = 0.039). A total of 62 patients did not require home medical care. Univariate logistic regression analysis identified length of ICU stay as a significant factor associated with the need for home medical care (p = 0.045). In paediatric ICU patients, postoperative admission, lower heart rate at admission, absence of pre-admission CPA and no mechanical ventilation predicted successful home discharge. The need for home medical care was significantly associated with length of ICU stay. Early and appropriate nursing interventions can be considered for paediatric ICU patients and their families, leading to the provision of high-quality nursing care.
- Open Access
- 23 February 2026
- Published by Wiley in Nursing in Critical Care
- Vol. 31 (2)
Predictors for Home Discharge and Need for Medical Care at Home in Paediatric ICU Patients: A Single‐Centre Retrospective Study
Background: The number of children with medical complexity at home has been increasing. To facilitate a smooth transition to home care for these children after discharge from the intensive care unit (ICU), early nursing interventions and family training are essential. Aim: This study examined factors that predict home discharge and the need for medical care at home using routine clinical information at the time of ICU admission. Study Design: This study included paediatric patients under the age of 16 who were admitted to the ICU. Clinical data were extracted from medical records. Univariate and multivariate analyses were conducted using logistic regression to identify relevant factors. Receiver operating characteristic (ROC) analysis was performed to determine the cut‐off values. Results: One hundred and thirty‐one patients were included, of whom 82 patients were discharged home. Multivariate analysis using logistic regression identified the following independent predictors of home discharge: postoperative admission ( p = 0.024), lower heart rate at admission ( p = 0.016), absence of cardiopulmonary arrest immediately before ICU admission (CPA) ( p = 0.012) and no mechanical ventilation within the first hour of ICU admission ( p = 0.044). ROC analysis for heart rate at admission yielded a cut‐off value of 131 bpm ( p = 0.039). A total of 62 patients did not require home medical care. Univariate logistic regression analysis identified length of ICU stay as a significant factor associated with the need for home medical care ( p = 0.045). Conclusions: In paediatric ICU patients, postoperative admission, lower heart rate at admission, absence of pre‐admission CPA and no mechanical ventilation predicted successful home discharge. The need for home medical care was significantly associated with length of ICU stay. Relevance to Clinical Practice: Early and appropriate nursing interventions can be considered for paediatric ICU patients and their families, leading to the provision of high‐quality nursing care.
- 23 February 2026
- Published by Wiley in Nursing in Critical Care
- Vol. 31 (2)
Open AccessPredictors for Home Discharge and Need for Medical Care at Home in Paediatric ICU Patients: A Single‐Centre Retrospective Study
Background: The number of children with medical complexity at home has been increasing. To facilitate a smooth transition to home care for these children after discharge from the intensive care unit (ICU), early nursing interventions and family training are essential. Aim: This study examined factors that predict home discharge and the need for medical care at home using routine clinical information at the time of ICU admission. Study Design: This study included paediatric patients under the age of 16 who were admitted to the ICU. Clinical data were extracted from medical records. Univariate and multivariate analyses were conducted using logistic regression to identify relevant factors. Receiver operating characteristic (ROC) analysis was performed to determine the cut‐off values. Results: One hundred and thirty‐one patients were included, of whom 82 patients were discharged home. Multivariate analysis using logistic regression identified the following independent predictors of home discharge: postoperative admission ( p = 0.024), lower heart rate at admission ( p = 0.016), absence of cardiopulmonary arrest immediately before ICU admission (CPA) ( p = 0.012) and no mechanical ventilation within the first hour of ICU admission ( p = 0.044). ROC analysis for heart rate at admission yielded a cut‐off value of 131 bpm ( p = 0.039). A total of 62 patients did not require home medical care. Univariate logistic regression analysis identified length of ICU stay as a significant factor associated with the need for home medical care ( p = 0.045). Conclusions: In paediatric ICU patients, postoperative admission, lower heart rate at admission, absence of pre‐admission CPA and no mechanical ventilation predicted successful home discharge. The need for home medical care was significantly associated with length of ICU stay. Relevance to Clinical Practice: Early and appropriate nursing interventions can be considered for paediatric ICU patients and their families, leading to the provision of high‐quality nursing care.
- Open Access
- 17 December 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 49 (4) , 1967-1972
Assessment of gastric emptying using 13C-acetate breath test with semi-solid diet after gastric cancer surgery and strategies for nutritional guidance
- 17 December 2025
- Published by Elsevier in Asian Journal of Surgery
- Vol. 49 (4) , 1967-1972
Open AccessAssessment of gastric emptying using 13C-acetate breath test with semi-solid diet after gastric cancer surgery and strategies for nutritional guidance
- Open Access
- 27 September 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (1)
A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease
Objective: This study aimed to establish a novel severity classification for intestinal Behçet's disease (BD) (SCIBD) and validate its criteria across multiple institutions. Methods: Five parameters, including abdominal pain, tenderness, intestinal bleeding, serum C‐reactive protein (CRP) level, and endoscopic findings, were identified to assess the severity of intestinal BD. Disease severity was categorized into remission and mild, moderate, or severe disease based on the criteria of each factor. This study also evaluated the correlation among the SCIBD scale, serum biomarkers, former disease activity for intestinal BD (DAIBD), and treatment decisions. Results: A total of 146 patients with intestinal BD and simple ulcers were retrospectively enrolled from 14 institutions between April and November 2022. As SCIBD severity increased, CRP and DAIBD levels significantly increased, whereas serum albumin levels decreased in the whole population. Similar correlations have been observed even in patients with intestinal BD. Antitumor necrosis factor‐alpha treatment was also significantly more common in severe cases (49.4%) than in moderate cases (20.8%; p = 0.001). However, the proportion of patients requiring corticosteroids was comparable between the moderate and severe disease groups (39.6% vs. 33.3%). In addition, no significant differences were observed in the frequency of corticosteroid treatment, anti‐TNF‐α treatment, or surgery among the four groups: quiescent, mild, moderate, and severe cases of DAIBD. SCIBD was changed after treatment with corticosteroids and TNF‐α according to improving clinical, biological, and endoscopic findings. Conclusions: The severity assessment of intestinal BD using our novel criteria correlated with appropriate treatment decisions, prognosis prediction, and treatment responses.
- 27 September 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 38 (1)
Open AccessA Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease
Objective: This study aimed to establish a novel severity classification for intestinal Behçet's disease (BD) (SCIBD) and validate its criteria across multiple institutions. Methods: Five parameters, including abdominal pain, tenderness, intestinal bleeding, serum C‐reactive protein (CRP) level, and endoscopic findings, were identified to assess the severity of intestinal BD. Disease severity was categorized into remission and mild, moderate, or severe disease based on the criteria of each factor. This study also evaluated the correlation among the SCIBD scale, serum biomarkers, former disease activity for intestinal BD (DAIBD), and treatment decisions. Results: A total of 146 patients with intestinal BD and simple ulcers were retrospectively enrolled from 14 institutions between April and November 2022. As SCIBD severity increased, CRP and DAIBD levels significantly increased, whereas serum albumin levels decreased in the whole population. Similar correlations have been observed even in patients with intestinal BD. Antitumor necrosis factor‐alpha treatment was also significantly more common in severe cases (49.4%) than in moderate cases (20.8%; p = 0.001). However, the proportion of patients requiring corticosteroids was comparable between the moderate and severe disease groups (39.6% vs. 33.3%). In addition, no significant differences were observed in the frequency of corticosteroid treatment, anti‐TNF‐α treatment, or surgery among the four groups: quiescent, mild, moderate, and severe cases of DAIBD. SCIBD was changed after treatment with corticosteroids and TNF‐α according to improving clinical, biological, and endoscopic findings. Conclusions: The severity assessment of intestinal BD using our novel criteria correlated with appropriate treatment decisions, prognosis prediction, and treatment responses.
- Open Access
- 30 April 2025
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 23 (2) , 157-169
Early resolution of bowel urgency by budesonide foam enema results in improved quality of life in patients with ulcerative colitis: a multicenter prospective observational study
Background/Aims: Bowel urgency is an important symptom for quality of life determination in patients with ulcerative colitis (UC). Few clinical studies have focused on bowel urgency as an efficacy endpoint. Budesonide foam enema has shown efficacy for clinical and endoscopic improvement in mild-to-moderate UC. We evaluated the improvement of clinical symptoms (bowel urgency), safety, and treatment impact of twice-daily budesonide foam enema on the quality of life in patients with UC.Methods: This open-label, multicenter, prospective observational study comprised a 4-week observation period assessing the effectiveness and safety of twice-daily budesonide foam enema. Mild-to-moderate UC patients who had bowel urgency were included. Patients collected data daily in an electronic patient-reported outcome system or logbooks. The primary endpoint was the rate of resolution of bowel urgency at the end of the 4-week observation period. The rate of bowel incontinence was also assessed. Results: Sixty-one patients were enrolled. Of patients with a final evaluation, the rate of resolution of bowel urgency was 58.5% (31/53; 95% confidence interval, 44.1%–71.9%). Bowel urgency decreased over time, with a significant difference observed on day 7 versus day 0. Bowel incontinence showed a decreasing trend from day 5, with a significant difference confirmed on day 12 versus day 0. The clinical remission rate was 64.4% (38/59; 95% confidence interval, 50.9%–76.4%). One adverse event not related to budesonide rectal foam occurred. Conclusions: The findings suggest that bowel urgency can be improved early with twice-daily budesonide foam enema. No new safety signals were observed.
- 30 April 2025
- Published by Korean Association for the Study of Intestinal Diseases in Intestinal Research
- Vol. 23 (2) , 157-169
Open AccessEarly resolution of bowel urgency by budesonide foam enema results in improved quality of life in patients with ulcerative colitis: a multicenter prospective observational study
Background/Aims: Bowel urgency is an important symptom for quality of life determination in patients with ulcerative colitis (UC). Few clinical studies have focused on bowel urgency as an efficacy endpoint. Budesonide foam enema has shown efficacy for clinical and endoscopic improvement in mild-to-moderate UC. We evaluated the improvement of clinical symptoms (bowel urgency), safety, and treatment impact of twice-daily budesonide foam enema on the quality of life in patients with UC.Methods: This open-label, multicenter, prospective observational study comprised a 4-week observation period assessing the effectiveness and safety of twice-daily budesonide foam enema. Mild-to-moderate UC patients who had bowel urgency were included. Patients collected data daily in an electronic patient-reported outcome system or logbooks. The primary endpoint was the rate of resolution of bowel urgency at the end of the 4-week observation period. The rate of bowel incontinence was also assessed. Results: Sixty-one patients were enrolled. Of patients with a final evaluation, the rate of resolution of bowel urgency was 58.5% (31/53; 95% confidence interval, 44.1%–71.9%). Bowel urgency decreased over time, with a significant difference observed on day 7 versus day 0. Bowel incontinence showed a decreasing trend from day 5, with a significant difference confirmed on day 12 versus day 0. The clinical remission rate was 64.4% (38/59; 95% confidence interval, 50.9%–76.4%). One adverse event not related to budesonide rectal foam occurred. Conclusions: The findings suggest that bowel urgency can be improved early with twice-daily budesonide foam enema. No new safety signals were observed.
- 3 March 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 37 (4) , 319-351
Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases
In recent years, we have seen a considerable increase in the number of patients with inflammatory bowel diseases of unknown etiology, including both Crohn's disease and ulcerative colitis. Inflammatory bowel diseases can cause intestinal lesions throughout the gastrointestinal tract, necessitating gastrointestinal endoscopy for examining all relevant aspects, especially lesion characteristics, for differential diagnosis and histological diagnosis, to select the appropriate treatment options, determine treatment effectiveness, etc. Specific guidelines are necessary to ensure that endoscopy can be performed in a safe and more tailored and efficient manner, especially since gastrointestinal endoscopy, including enteroscopy, is a common procedure worldwide, including in Japan. Within this context, the Japan Gastroenterological Endoscopy Society has formulated the “Guidelines for the Endoscopic Diagnosis and Treatment of Inflammatory Bowel Diseases” to provide detailed guidelines regarding esophagogastroduodenoscopy, enteroscopy, and colonoscopy procedures for definitive diagnosis, as well as determination of treatment effectiveness in clinical cases of inflammatory bowel diseases.
- 3 March 2025
- Published by Wiley in Digestive Endoscopy
- Vol. 37 (4) , 319-351
Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases
In recent years, we have seen a considerable increase in the number of patients with inflammatory bowel diseases of unknown etiology, including both Crohn's disease and ulcerative colitis. Inflammatory bowel diseases can cause intestinal lesions throughout the gastrointestinal tract, necessitating gastrointestinal endoscopy for examining all relevant aspects, especially lesion characteristics, for differential diagnosis and histological diagnosis, to select the appropriate treatment options, determine treatment effectiveness, etc. Specific guidelines are necessary to ensure that endoscopy can be performed in a safe and more tailored and efficient manner, especially since gastrointestinal endoscopy, including enteroscopy, is a common procedure worldwide, including in Japan. Within this context, the Japan Gastroenterological Endoscopy Society has formulated the “Guidelines for the Endoscopic Diagnosis and Treatment of Inflammatory Bowel Diseases” to provide detailed guidelines regarding esophagogastroduodenoscopy, enteroscopy, and colonoscopy procedures for definitive diagnosis, as well as determination of treatment effectiveness in clinical cases of inflammatory bowel diseases.
- Open Access
- 14 February 2025
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 60 (5) , 573-582
Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel
Background: Small bowel (SB) lesions in Crohn’s disease (CD) are often asymptomatic despite being highly active. Fecal calprotectin (FC) is the most widely used biomarker of CD activity, but its drawbacks include a large intra-individual sample variability and the burden of collecting stool samples. Meanwhile, serum leucine-rich alpha-2 glycoprotein (LRG) has recently attracted attention as a biomarker that can address the limitations of FC. This study determined the diagnostic accuracy of LRG and its cut-off values for diagnosing CD activity in SB. Methods: This was a retrospective, multi-center study of CD patients undergoing retrograde balloon-assisted endoscopy. For ileal- and ileocolonic-type patients with a colon SES-CD score of 0, we estimated the receiver operating characteristic curve of LRG and determined the cut-off value to achieve a target sensitivity level of 80%. Results: Among 285 patients with SB lesions, LRG had an area under the curve (AUC) of 0.72 (95% CI 0.67–0.78) with a sensitivity of 80.2% and specificity of 47.2% for a cut-off value of 10.5 when diagnosing endoscopic remission (modified SES-CD ≤ 3), while it had an AUC of 0.72 (95% CI 0.65–0.78) with a sensitivity of 81.2% and specificity of 46.2% for a cut-off value of 10.1 when diagnosing complete ulcer healing (modified SES-CD ≤ 1). Conclusion: LRG was effective for diagnosing CD activity in SB, specifically with cut-off values of 10.5 and 10.1 for endoscopic remission and complete ulcer healing, respectively. A future prospective validation study will assess its clinical utility. Graphical
- 14 February 2025
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 60 (5) , 573-582
Open AccessDiagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel
Background: Small bowel (SB) lesions in Crohn’s disease (CD) are often asymptomatic despite being highly active. Fecal calprotectin (FC) is the most widely used biomarker of CD activity, but its drawbacks include a large intra-individual sample variability and the burden of collecting stool samples. Meanwhile, serum leucine-rich alpha-2 glycoprotein (LRG) has recently attracted attention as a biomarker that can address the limitations of FC. This study determined the diagnostic accuracy of LRG and its cut-off values for diagnosing CD activity in SB. Methods: This was a retrospective, multi-center study of CD patients undergoing retrograde balloon-assisted endoscopy. For ileal- and ileocolonic-type patients with a colon SES-CD score of 0, we estimated the receiver operating characteristic curve of LRG and determined the cut-off value to achieve a target sensitivity level of 80%. Results: Among 285 patients with SB lesions, LRG had an area under the curve (AUC) of 0.72 (95% CI 0.67–0.78) with a sensitivity of 80.2% and specificity of 47.2% for a cut-off value of 10.5 when diagnosing endoscopic remission (modified SES-CD ≤ 3), while it had an AUC of 0.72 (95% CI 0.65–0.78) with a sensitivity of 81.2% and specificity of 46.2% for a cut-off value of 10.1 when diagnosing complete ulcer healing (modified SES-CD ≤ 1). Conclusion: LRG was effective for diagnosing CD activity in SB, specifically with cut-off values of 10.5 and 10.1 for endoscopic remission and complete ulcer healing, respectively. A future prospective validation study will assess its clinical utility. Graphical
- Open Access
- 4 March 2023
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 17 (8) , 1193-1206
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
Background and Aims: Perianal lesion is a refractory phenotype of Crohn’s disease [CD] with significantly diminished quality of life. We evaluated the clinical characteristics of perianal lesions in newly diagnosed CD patients and the impact of perianal lesions on the quality of life in Japanese patients with CD. Methods: Patients newly diagnosed with CD after June 2016 were included between December 2018 and June 2020 from the Inception Cohort Registry Study of Patients with CD [iCREST-CD]. Results: Perianal lesions were present in 324 [48.2%] of 672 patients with newly diagnosed CD; 71.9% [233/324] were male. The prevalence of perianal lesions was higher in patients aged <40 years vs ≥40 years, and it decreased with age. Perianal fistula [59.9%] and abscess [30.6%] were the most common perianal lesions. In multivariate analyses, male sex, age <40 years and ileocolonic disease location were significantly associated with a high prevalence of perianal lesions, whereas stricturing behaviour and alcohol intake were associated with low prevalence. Fatigue was more frequent [33.3% vs 21.6%] while work productivity and activity impairment-work time missed [36.3% vs 29.5%] and activity impairment [51.9% vs 41.1%] were numerically higher in patients with than those without perianal lesions. Conclusions: At the time of CD diagnosis, approximately half of the patients had perianal lesions; perianal abscesses and perianal fistulas were the most common. Young age, male sex, disease location and behaviour were significantly associated with the presence of perianal lesions. The presence of perianal lesion was associated with fatigue and impairment of daily activities. Clinical trials registry: University Hospital Medical Information Network Clinical Trials Registry System [UMIN-CTR, UMIN000032237].
- 4 March 2023
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 17 (8) , 1193-1206
Open AccessDiagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn’s Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn’s Disease (iCREST-CD)
Background and Aims: Perianal lesion is a refractory phenotype of Crohn’s disease [CD] with significantly diminished quality of life. We evaluated the clinical characteristics of perianal lesions in newly diagnosed CD patients and the impact of perianal lesions on the quality of life in Japanese patients with CD. Methods: Patients newly diagnosed with CD after June 2016 were included between December 2018 and June 2020 from the Inception Cohort Registry Study of Patients with CD [iCREST-CD]. Results: Perianal lesions were present in 324 [48.2%] of 672 patients with newly diagnosed CD; 71.9% [233/324] were male. The prevalence of perianal lesions was higher in patients aged <40 years vs ≥40 years, and it decreased with age. Perianal fistula [59.9%] and abscess [30.6%] were the most common perianal lesions. In multivariate analyses, male sex, age <40 years and ileocolonic disease location were significantly associated with a high prevalence of perianal lesions, whereas stricturing behaviour and alcohol intake were associated with low prevalence. Fatigue was more frequent [33.3% vs 21.6%] while work productivity and activity impairment-work time missed [36.3% vs 29.5%] and activity impairment [51.9% vs 41.1%] were numerically higher in patients with than those without perianal lesions. Conclusions: At the time of CD diagnosis, approximately half of the patients had perianal lesions; perianal abscesses and perianal fistulas were the most common. Young age, male sex, disease location and behaviour were significantly associated with the presence of perianal lesions. The presence of perianal lesion was associated with fatigue and impairment of daily activities. Clinical trials registry: University Hospital Medical Information Network Clinical Trials Registry System [UMIN-CTR, UMIN000032237].
- 9 November 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 34 (7) , 1278-1296
Guidelines for endoscopic balloon dilation in treating Crohn's disease‐associated small intestinal strictures (supplement to the Clinical Practice Guidelines for Enteroscopy)
Balloon‐assisted enteroscopy allows endoscopic treatments in the deeper segments of the small bowel. Endoscopic balloon dilation has become a popular minimally invasive alternative for the treatment of Crohn's disease‐associated small intestinal strictures. As a supplement to the Clinical Practice Guidelines for Enteroscopy, the Japan Gastroenterological Endoscopy Society's Working Committee has developed the present “Guidelines for endoscopic balloon dilation in treating Crohn's disease‐associated small intestinal strictures,” based on new scientific techniques and evidence. The guidelines cover standard procedures for the insertion route of the balloon endoscope, bowel preparation, indications, procedure‐related complications, efficacy, target diameter and duration, management of multiple strictures, and the current state of combined and alternative treatments. Unresolved future research questions are also listed in this guideline.
- 9 November 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 34 (7) , 1278-1296
Guidelines for endoscopic balloon dilation in treating Crohn's disease‐associated small intestinal strictures (supplement to the Clinical Practice Guidelines for Enteroscopy)
Balloon‐assisted enteroscopy allows endoscopic treatments in the deeper segments of the small bowel. Endoscopic balloon dilation has become a popular minimally invasive alternative for the treatment of Crohn's disease‐associated small intestinal strictures. As a supplement to the Clinical Practice Guidelines for Enteroscopy, the Japan Gastroenterological Endoscopy Society's Working Committee has developed the present “Guidelines for endoscopic balloon dilation in treating Crohn's disease‐associated small intestinal strictures,” based on new scientific techniques and evidence. The guidelines cover standard procedures for the insertion route of the balloon endoscope, bowel preparation, indications, procedure‐related complications, efficacy, target diameter and duration, management of multiple strictures, and the current state of combined and alternative treatments. Unresolved future research questions are also listed in this guideline.